BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 15476584)

  • 1. Additive protective effects of estrogen and androgen treatment on trabecular bone in ovariectomized rats.
    Tivesten A; Movérare-Skrtic S; Chagin A; Venken K; Salmon P; Vanderschueren D; Sävendahl L; Holmäng A; Ohlsson C
    J Bone Miner Res; 2004 Nov; 19(11):1833-9. PubMed ID: 15476584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative impact of androgen and estrogen receptor activation in the effects of androgens on trabecular and cortical bone in growing male mice: a study in the androgen receptor knockout mouse model.
    Venken K; De Gendt K; Boonen S; Ophoff J; Bouillon R; Swinnen JV; Verhoeven G; Vanderschueren D
    J Bone Miner Res; 2006 Apr; 21(4):576-85. PubMed ID: 16598378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats.
    Armamento-Villareal R; Sheikh S; Nawaz A; Napoli N; Mueller C; Halstead LR; Brodt MD; Silva MJ; Galbiati E; Caruso PL; Civelli M; Civitelli R
    J Bone Miner Res; 2005 Dec; 20(12):2178-88. PubMed ID: 16294271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of recombinant human growth hormone and insulin-like growth factor-I, with or without 17 beta-estradiol, on bone and mineral homeostasis of aged ovariectomized rats.
    Verhaeghe J; van Bree R; Van Herck E; Thomas H; Skottner A; Dequeker J; Mosekilde L; Einhorn TA; Bouillon R
    J Bone Miner Res; 1996 Nov; 11(11):1723-35. PubMed ID: 8915780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence from the aged orchidectomized male rat model that 17beta-estradiol is a more effective bone-sparing and anabolic agent than 5alpha-dihydrotestosterone.
    Vandenput L; Boonen S; Van Herck E; Swinnen JV; Bouillon R; Vanderschueren D
    J Bone Miner Res; 2002 Nov; 17(11):2080-6. PubMed ID: 12412816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new synthetic steroid, osaterone acetate (TZP-4238), increases cortical bone mass and strength by enhancing bone formation in ovariectomized rats.
    Fuse H; Fukumoto S; Sone H; Miyata Y; Saito T; Nakayama K; Takahashi H; Matsumoto T; Ogata E
    J Bone Miner Res; 1997 Apr; 12(4):590-7. PubMed ID: 9101370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both hPTH(1-34) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture.
    Lane NE; Yao W; Kinney JH; Modin G; Balooch M; Wronski TJ
    J Bone Miner Res; 2003 Dec; 18(12):2105-15. PubMed ID: 14672345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dihydrotestosterone alone and combined with estrogen on bone mineral density, bone growth, and formation rates in ovariectomized rats.
    Coxam V; Bowman BM; Mecham M; Roth CM; Miller MA; Miller SC
    Bone; 1996 Aug; 19(2):107-14. PubMed ID: 8853853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tibolone exerts its protective effect on trabecular bone loss through the estrogen receptor.
    Ederveen AG; Kloosterboer HJ
    J Bone Miner Res; 2001 Sep; 16(9):1651-7. PubMed ID: 11547834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effect of soy protein, soy isoflavones, and 17beta-estradiol on bone metabolism in adult ovariectomized rats.
    Cai DJ; Zhao Y; Glasier J; Cullen D; Barnes S; Turner CH; Wastney M; Weaver CM
    J Bone Miner Res; 2005 May; 20(5):828-39. PubMed ID: 15824856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats.
    Marie PJ; Hott M; Modrowski D; De Pollak C; Guillemain J; Deloffre P; Tsouderos Y
    J Bone Miner Res; 1993 May; 8(5):607-15. PubMed ID: 8511988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined treatment with a beta-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice.
    Pierroz DD; Bouxsein ML; Rizzoli R; Ferrari SL
    Bone; 2006 Aug; 39(2):260-7. PubMed ID: 16531131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen supplementation modulates effects of the endocrine disrupting pollutant PCB126 in rat bone and uterus: diverging effects in ovariectomized and intact animals.
    Lind PM; Eriksen EF; Lind L; Orberg J; Sahlin L
    Toxicology; 2004 Jul; 199(2-3):129-36. PubMed ID: 15147787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nonprostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized rats.
    Ke HZ; Crawford DT; Qi H; Simmons HA; Owen TA; Paralkar VM; Li M; Lu B; Grasser WA; Cameron KO; Lefker BA; DaSilva-Jardine P; Scott DO; Zhang Q; Tian XY; Jee WS; Brown TA; Thompson DD
    J Bone Miner Res; 2006 Apr; 21(4):565-75. PubMed ID: 16598377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidences for antiosteoporotic and selective estrogen receptor modulator activity of silymarin compared with ethinylestradiol in ovariectomized rats.
    El-Shitany NA; Hegazy S; El-Desoky K
    Phytomedicine; 2010 Feb; 17(2):116-25. PubMed ID: 19577454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of estradiol and dihydrotestosterone on osteoblast gene expression in osteopenic ovariectomized rats.
    Davey RA; Morris HA
    J Bone Miner Metab; 2005; 23(3):212-8. PubMed ID: 15838623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
    Shen V; Birchman R; Wu DD; Lindsay R
    J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Droloxifene prevents ovariectomy-induced bone loss in tibiae and femora of aged female rats: a dual-energy X-ray absorptiometric and histomorphometric study.
    Chen HK; Ke HZ; Jee WS; Ma YF; Pirie CM; Simmons HA; Thompson DD
    J Bone Miner Res; 1995 Aug; 10(8):1256-62. PubMed ID: 8585430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The thyroid hormone receptor beta-specific agonist GC-1 selectively affects the bone development of hypothyroid rats.
    Freitas FR; Capelo LP; O'Shea PJ; Jorgetti V; Moriscot AS; Scanlan TS; Williams GR; Zorn TM; Gouveia CH
    J Bone Miner Res; 2005 Feb; 20(2):294-304. PubMed ID: 15647824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the androgen receptor in skeletal homeostasis: the androgen-resistant testicular feminized male mouse model.
    Vandenput L; Swinnen JV; Boonen S; Van Herck E; Erben RG; Bouillon R; Vanderschueren D
    J Bone Miner Res; 2004 Sep; 19(9):1462-70. PubMed ID: 15312246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.